TAMs为靶点的抗肿瘤治疗研究进展

肿瘤微环境与肿瘤细胞通过分子和细胞间的相互作用，在肿瘤的发生发展和转移扩散中具有重要意义。肿瘤相关巨噬细胞（TAMs）作为肿瘤微环境中数量最多的炎症细胞群之一，在肿瘤进展中起到重要作用。肿瘤细胞通过释放多种趋化因子、细胞因子和生长因子招募巨噬细胞，并使其向M2型巨噬细胞类似的特性发展。同时，巨噬细胞释放多种因子，促进肿瘤细胞的生长、血管新生、迁移、侵袭、侵入血管并最终形成远处转移。TAMs在肿瘤组织中的密度与肿瘤患者治疗失败和不良预后密切相关，以TAMs为靶点的抗肿瘤治疗相关研究近年来取得重大进展。在肿瘤发生发展中根据TAMs的作用机制，以TAMs为靶点的抗肿瘤治疗策略是抑制肿瘤微环境中巨噬细胞招募、TAMs生存能力、TAMs表型即由M2型转化为M1型的重塑。本文就TAMs为靶点的抗肿瘤治疗最新进展进行综述。 

Advances in research on tumor-associated macrophages as potential target of anti-tumor therapy

Tumor cells and the tumor microenvironment interact through molecular and cellular mechanisms to promote tumorigenesis and tumor migration. The tumor microenvironment is important in tumorigenesis and tumor progression. Tumor-associated macrophages (TAMs), which are ones of the most inflammatory cells in the tumor microenvironment, have significant influence on tumor development. Tumor cells recruit macrophages by releasing chemokines, cytokines, and growth factors, and switch them into M2-type macrophages. Macrophages also release many factors which are important to some stages of tumor development, including tumor growth, angiogenesis, migration, invasion, and distant metastasis. TAM density is associated with treatment failure and poor prognosis in tumor patients. Great progress has recently been made in targeting TAMs for anti-tumor therapy. Strategies of targeting TAMs for anti-tumor therapy include suppression of macrophage recruitment, inhibition of TAM viability, reinstating the TAM phenotype, and transforming M2-type macrophages to M1-type macrophages. This article reviews the latest progress in the field based on TAM functions.